Ocean Pharmaceutical Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Ocean Pharmaceutical Pharmaceutical Export Portfolio Dataset — 2 Products, $132.4K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Ocean Pharmaceutical — Pharmaceutical Exporter Profile (2026) | 2 Products, $132.4K Trade | TransData Nexus

Ocean Pharmaceutical

Indian Pharmaceutical Exporter · Respiratory & OTC Specialist · $132.4K Total Trade · DGFT Verified

Ocean Pharmaceutical is an Indian pharmaceutical exporter with a total trade value of $132.4K across 2 products in 2 therapeutic categories. Based on 24 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Aminophylline ($107.5K), Ledipasvir ($24.9K), .

Ocean Pharmaceutical — Export Portfolio & Destination Treemap

Ocean Pharmaceutical pharmaceutical export portfolio — 2 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Ocean Pharmaceutical? — Company Overview & Market Position

Ocean Pharmaceutical, established in 2016, is a privately held pharmaceutical company headquartered in Vadodara, Gujarat, India. The company specializes in the development, manufacturing, and marketing of a diverse range of pharmaceutical formulations, including tablets, capsules, dry powder injections, lyophilized injections, ointments, and inhalers. Their product portfolio spans various therapeutic areas such as oncology, anti-diabetic, cardiology, pain management, gynecology, anti-infectives, vitamins, minerals, nutrients, gastrointestinal, anti-osteoporosis, anti-malarial, immunosuppressants, anti-bacterial, anti-asthmatics, anti-allergy, contrast media, effervescent tablets, and vaccines.

The company's commitment to quality and customer satisfaction has led to a significant presence in the international market, exporting to over 45 countries. Ocean Pharmaceutical's dedication to providing high-quality products at reasonable prices has positioned it as a leading exporter of various pharmaceutical drugs. (about.me)

What Does Ocean Pharmaceutical Export? — Product Portfolio Analysis

Top Products by Export Value

1Aminophylline$107.5K

Product Portfolio — Top 2 by Export Value

Ocean Pharmaceutical exports 2 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Aminophylline	Respiratory & OTC	$107.5K	18	1.8%	6
2	Ledipasvir	Antiviral & HIV Medications	$24.9K	6	2.2%	5

Ocean Pharmaceutical exports 2 pharmaceutical products across 2 therapeutic categories with a total export value of $132.4K. The top category is Respiratory & OTC (81.2% of portfolio), followed by Antiviral & HIV Medications (18.8%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Ocean Pharmaceutical — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Ocean Pharmaceutical operates a WHO–cGMP certified manufacturing facility located in Vadodara, Gujarat, India. This state-of-the-art plant is equipped to produce a wide range of pharmaceutical formulations, including tablets, capsules, dry powder injections, lyophilized injections, ointments, and inhalers. The facility adheres to stringent quality control measures to ensure the safety and efficacy of its products. (about.me)

3Key Leadership

The leadership team at Ocean Pharmaceutical is headed by Managing Director Mr. Yogesh Parmar, who has been instrumental in steering the company towards its current growth trajectory. Under his guidance, the company has expanded its product portfolio and strengthened its presence in international markets. The team comprises professionals with expertise in various domains, including research and development, manufacturing, quality control, and marketing, contributing to the company's success.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Ocean Pharmaceutical Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Ocean Pharmaceutical has made significant strides in regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has obtained necessary regulatory approvals and certifications to export its pharmaceutical formulations to these regions. This compliance with international standards underscores the company's commitment to quality and safety, facilitating its entry into these competitive markets.

2Emerging Markets

Ocean Pharmaceutical has expanded its reach to emerging markets in Africa, Latin America, and Southeast Asia. The company's adherence to WHO prequalification standards has enabled it to access these markets, providing essential medicines to regions with significant healthcare needs. This strategic expansion aligns with the company's mission to make quality healthcare solutions accessible globally.

3Geographic Strategy

Ocean Pharmaceutical's geographic strategy demonstrates a balanced approach to market diversification. While the company has a strong presence in regulated markets, it has also strategically penetrated emerging markets, mitigating concentration risk. This diversification allows the company to leverage growth opportunities across different regions, enhancing its global footprint and resilience.

Ocean Pharmaceutical — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Ocean Pharmaceutical has registered its manufacturing facility with the U.S. Food and Drug Administration (FDA), ensuring compliance with U.S. regulatory standards. The company has also filed Abbreviated New Drug Applications (ANDAs) for its generic formulations, facilitating market entry in the U.S. While specific details regarding Drug Master File (DMF) filings and inspection history are not publicly disclosed, the company's adherence to international quality standards suggests a commitment to maintaining high manufacturing practices.

2WHO & EU GMP

Ocean Pharmaceutical's manufacturing facility holds WHO–cGMP certification, indicating compliance with World Health Organization standards for Good Manufacturing Practices. This certification is crucial for exporting pharmaceutical products to various international markets. Additionally, the company's adherence to EU GMP standards further demonstrates its commitment to quality and safety in pharmaceutical manufacturing. (about.me)

3CDSCO & Indian Regulatory

Ocean Pharmaceutical — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Ocean Pharmaceutical operates in a competitive landscape, with several companies offering similar pharmaceutical formulations. While specific market share data is not publicly available, the company's focus on high-quality standards and customer-centric approach positions it favorably in the market. Its diverse product portfolio and adherence to international quality standards enable it to compete effectively across various therapeutic segments.

2Key Differentiators

Ocean Pharmaceutical's key differentiators include its commitment to quality, adherence to international manufacturing standards, and a diverse product portfolio covering a wide range of therapeutic areas. The company's focus on affordability without compromising quality makes its products accessible to a broader patient population. Additionally, its strategic expansion into emerging markets demonstrates a proactive approach to global healthcare needs.

3Strategic Position

Ocean Pharmaceutical's current strategic direction emphasizes the development and export of generic pharmaceutical formulations. The company's adherence to international quality standards and regulatory compliance supports its position in the global market. Looking ahead, Ocean Pharmaceutical aims to expand its product range, strengthen its presence in existing markets, and explore new therapeutic areas, aligning with its mission to provide affordable and high-quality healthcare solutions worldwide.

Buyer Due Diligence Brief — Evaluating Ocean Pharmaceutical as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Ocean Pharmaceutical has demonstrated a consistent track record in manufacturing and exporting pharmaceutical products. The company's export volume and consistency reflect its reliability as a supplier. Indicators of reliability include adherence to international quality standards, regulatory compliance, and a customer-centric approach, all contributing to its reputation in the pharmaceutical industry.

2Certifications to Verify

Importers should verify the following certifications when considering Ocean Pharmaceutical as a supplier:

FDA Facility Registration: Confirm the company's registration with the U.S. Food and Drug Administration to ensure compliance with U.S. regulatory standards.

WHO–cGMP Certification: Verify the manufacturing facility's certification by the World Health Organization for Good Manufacturing Practices, indicating adherence to international quality standards.

Frequently Asked Questions — Ocean Pharmaceutical

How many pharmaceutical products does Ocean Pharmaceutical export from India?

Ocean Pharmaceutical exports 2 pharmaceutical products across 2 therapeutic categories. The top exports are Aminophylline ($107.5K), Ledipasvir ($24.9K). Total export value is $132.4K.

What is Ocean Pharmaceutical's total pharmaceutical export value?

Ocean Pharmaceutical's total pharmaceutical export value is $132.4K, based on 24 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Ocean Pharmaceutical cover?

Ocean Pharmaceutical exports across 2 therapeutic categories. The largest are Respiratory & OTC (81.2%, 1 products), Antiviral & HIV Medications (18.8%, 1 products).

Get Full Ocean Pharmaceutical Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.